These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19236029)

  • 21. Free energy calculations on the binding of novel thiolactomycin derivatives to E. coli fatty acid synthase I.
    Steinbrecher T; Case DA; Labahn A
    Bioorg Med Chem; 2012 Jun; 20(11):3446-53. PubMed ID: 22560835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Schiff-base-derived FabH inhibitors with dioxygenated rings as antibiotic agents.
    Zhou Y; Du QR; Sun J; Li JR; Fang F; Li DD; Qian Y; Gong HB; Zhao J; Zhu HL
    ChemMedChem; 2013 Mar; 8(3):433-41. PubMed ID: 23401291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platensimycin is a selective FabF inhibitor with potent antibiotic properties.
    Wang J; Soisson SM; Young K; Shoop W; Kodali S; Galgoci A; Painter R; Parthasarathy G; Tang YS; Cummings R; Ha S; Dorso K; Motyl M; Jayasuriya H; Ondeyka J; Herath K; Zhang C; Hernandez L; Allocco J; Basilio A; Tormo JR; Genilloud O; Vicente F; Pelaez F; Colwell L; Lee SH; Michael B; Felcetto T; Gill C; Silver LL; Hermes JD; Bartizal K; Barrett J; Schmatz D; Becker JW; Cully D; Singh SB
    Nature; 2006 May; 441(7091):358-61. PubMed ID: 16710421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structures of bacterial FabH suggest a molecular basis for the substrate specificity of the enzyme.
    Gajiwala KS; Margosiak S; Lu J; Cortez J; Su Y; Nie Z; Appelt K
    FEBS Lett; 2009 Sep; 583(17):2939-46. PubMed ID: 19665020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyrazolidine-3,5-diones and 5-hydroxy-1H-pyrazol-3(2H)-ones, inhibitors of UDP-N-acetylenolpyruvyl glucosamine reductase.
    Gilbert AM; Failli A; Shumsky J; Yang Y; Severin A; Singh G; Hu W; Keeney D; Petersen PJ; Katz AH
    J Med Chem; 2006 Oct; 49(20):6027-36. PubMed ID: 17004716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the resuscitation from the viable but non-culturable state in Enterococcus faecalis.
    Lleò MM; Benedetti D; Tafi MC; Signoretto C; Canepari P
    Environ Microbiol; 2007 Sep; 9(9):2313-20. PubMed ID: 17686027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of Schiff-Base-Derived with Dioxygenated Rings and Nitrogen Heterocycle as Potential β-Ketoacyl-acyl Carrier Protein Synthase III (FabH) Inhibitors.
    Zhou Y; Yang YS; Song XD; Lu L; Zhu HL
    Chem Pharm Bull (Tokyo); 2017; 65(2):178-185. PubMed ID: 28154310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel inhibitors of the condensing enzymes of the type II fatty acid synthase of pea (Pisum sativum).
    Jones AL; Herbert D; Rutter AJ; Dancer JE; Harwood JL
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):205-9. PubMed ID: 10727420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The vancomycin-nisin(1-12) hybrid restores activity against vancomycin resistant Enterococci.
    Arnusch CJ; Bonvin AM; Verel AM; Jansen WT; Liskamp RM; de Kruijff B; Pieters RJ; Breukink E
    Biochemistry; 2008 Dec; 47(48):12661-3. PubMed ID: 18989934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of a novel Enterococcus faecalis bacteriophage phiEF24C as a therapeutic candidate.
    Uchiyama J; Rashel M; Maeda Y; Takemura I; Sugihara S; Akechi K; Muraoka A; Wakiguchi H; Matsuzaki S
    FEMS Microbiol Lett; 2008 Jan; 278(2):200-6. PubMed ID: 18096017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationship-based screening of antibiotics against Gram-negative Acinetobacter baumannii.
    Lee JY; Jeong MC; Jeon D; Lee Y; Lee WC; Kim Y
    Bioorg Med Chem; 2017 Jan; 25(1):372-380. PubMed ID: 27840136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of administration mode of antibiotics on antibiotic resistance of Enterococcus faecalis in aquatic ecosystems.
    Yu D; Yi X; Ma Y; Yin B; Zhuo H; Li J; Huang Y
    Chemosphere; 2009 Aug; 76(7):915-20. PubMed ID: 19476969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro evaluation of the antimicrobial activity of HM-242, a novel antiseptic compound.
    Okunishi J; Nishihara Y; Maeda S; Ikeda M
    J Antibiot (Tokyo); 2009 Sep; 62(9):489-93. PubMed ID: 19575042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of synthetic compounds active against VRE: the role of the lipidated aminoglucose and the structure of glycopeptide binding pocket.
    Jia Y; Gonzalez-Zamora E; Ma N; Liu Z; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4594-9. PubMed ID: 16099650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temperature regulation of membrane composition in the Firmicute, Enterococcus faecalis, parallels that of Escherichia coli.
    Dong H; Cronan JE
    Environ Microbiol; 2021 May; 23(5):2683-2691. PubMed ID: 33830615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of a biologically active thiostrepton fragment.
    Nicolaou KC; Zak M; Rahimipour S; Estrada AA; Lee SH; O'Brate A; Giannakakou P; Ghadiri MR
    J Am Chem Soc; 2005 Nov; 127(43):15042-4. PubMed ID: 16248640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel FabH inhibitors: an updated article literature review (July 2012 to June 2013).
    Song H; Ao GZ; Li HQ
    Expert Opin Ther Pat; 2014 Jan; 24(1):19-27. PubMed ID: 24083428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).
    Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):158-62. PubMed ID: 19748426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nosocomial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital.
    Gómez-Gil R; Romero-Gómez MP; García-Arias A; Ubeda MG; Busselo MS; Cisterna R; Gutiérrez-Altés A; Mingorance J
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):175-9. PubMed ID: 19717261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery and modification of sulfur-containing heterocyclic pyrazoline derivatives as potential novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Yang YS; Zhang F; Gao C; Zhang YB; Wang XL; Tang JF; Sun J; Gong HB; Zhu HL
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4619-24. PubMed ID: 22721711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.